Extreme LongevityLongevityGenetics
What this study is
We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.
Study details
- Official title
- Searching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population
- Sponsor
- Albert Einstein College of Medicine
- Conditions
- Extreme Longevity
- Enrolling
- 2,000 people
- Starts
- 1998-07
- Est. completion
- 2032-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 65 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Ashkenazi Jewish, age 95+,
- Offspring of person age 95+,
- Offspring of parents who died age 70 or younger.
You can't join if
- Non-Ashkenazis
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Study locations (2)
2 openPrivate Homes
New York, New York, United States
- Wanda I Guzman, BA · Contact718-430-3838WANDA.GUZMAN@EINSTEINMED.EDU
Recruiting- Recruiting
Study team
Sponsor
Albert Einstein College of Medicine
Study ID 1998-125
Principal investigator
Nir Barzilai, MD
Albert Einstein College of Medicine
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.